Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -27.43%59.19M | -31.05%67.1M | -22.72%68.7M | -11.67%354.74M | -29.70%86.97M | -19.58%81.57M | -3.33%97.32M | 21.59%88.9M | 47.63%401.62M | 60.69%123.71M |
| Cost of revenue | -10.60%351.24M | 46.10%392.87M | ||||||||
| Gross profit | -60.09%3.49M | 177.59%8.76M | ||||||||
| Operating expense | -29.45%60.72M | -29.55%69.66M | -21.02%70.58M | 3.28%13.59M | -25.56%101.5M | -15.91%86.07M | -1.83%98.88M | 17.25%89.36M | 81.92%13.16M | 172.21%136.35M |
| Selling and administrative expenses | ---- | ---- | ---- | -32.09%5.26M | ---- | ---- | ---- | ---- | 50.79%7.75M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -32.09%5.26M | ---- | ---- | ---- | ---- | 50.79%7.75M | ---- |
| Other operating expenses | -28.84%61.24M | -29.17%70.14M | -21.60%70.72M | 28.23%9.89M | -24.93%103.35M | -16.44%86.07M | -4.01%99.03M | 17.44%90.2M | 58.77%7.71M | 170.57%137.67M |
| Total other operating income | --524K | 227.40%478K | -83.91%135K | -32.26%1.56M | 39.09%1.84M | ---- | -94.03%146K | 41.96%839K | -16.72%2.3M | 216.78%1.33M |
| Operating profit | 66.02%-1.53M | -63.93%-2.56M | -306.71%-1.88M | -129.24%-10.1M | -15.02%-14.54M | -388.60%-4.5M | -3,152.08%-1.56M | 85.09%-462K | -7.96%-4.41M | -309.49%-12.64M |
| Net non-operating interest income (expenses) | 51.55%-47K | 75.55%-67K | -50.00%-99K | 2.10%-475.96K | 78.21%-78K | -59.02%-97K | -914.81%-274K | -65.00%-66K | -481.61%-486.14K | -652.32%-358K |
| Non-operating interest expense | -51.55%47K | -75.55%67K | 50.00%99K | -2.10%475.96K | -78.21%78K | 59.02%97K | 914.81%274K | 65.00%66K | 481.61%486.14K | 652.32%358K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | -29.69%694.65K | 0 | -27.20%182K | 4.90%257K | 7.56%256K | -15.67%987.93K | 2,104.74%255K |
| Special income (charges) | 10.57%-11M | -12.3M | ||||||||
| Less:Negative goodwill immediately recognized | ---- | ---- | ---- | -10.57%11M | ---- | ---- | ---- | ---- | --12.3M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 64.30%-1.58M | -66.41%-2.63M | -627.21%-1.98M | -28.86%-20.88M | -14.70%-14.61M | -503.14%-4.42M | -1,028.24%-1.58M | 90.62%-272K | -441.50%-16.2M | -308.06%-12.74M |
| Income tax | 51.61%-75K | 114.37%140K | 75.63%-48K | -143.73%-604.5K | -16.82%722K | -137.17%-155K | -444.13%-974K | -171.38%-197K | 149.68%1.38M | 283.37%868K |
| Net income | 64.77%-1.5M | -357.95%-2.77M | -2,473.33%-1.93M | -15.29%-20.28M | -12.69%-15.34M | -270.76%-4.26M | -273.07%-604K | 97.64%-75K | -291.45%-17.59M | -413.84%-13.61M |
| Net income continuous operations | 64.77%-1.5M | -357.95%-2.77M | -2,473.33%-1.93M | -15.29%-20.28M | -12.69%-15.34M | -270.76%-4.26M | -273.07%-604K | 97.64%-75K | -395.94%-17.59M | -413.75%-13.61M |
| Noncontrolling interests | 0 | 0 | 0 | -77.42%247.29K | -45.95%387K | -248.63%-651K | 606.56%309K | 10,050.00%203K | 21,864.54%1.1M | 14,260.21%716K |
| Net income attributable to the company | 58.41%-1.5M | -202.96%-2.77M | -594.24%-1.93M | -9.86%-20.52M | -9.76%-15.72M | -127.41%-3.61M | -322.68%-913K | 91.25%-278K | -315.36%-18.68M | -439.86%-14.33M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 58.41%-1.5M | -202.96%-2.77M | -594.24%-1.93M | -9.86%-20.52M | -9.76%-15.72M | -127.41%-3.61M | -322.68%-913K | 91.25%-278K | -315.36%-18.68M | -439.86%-14.33M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 58.33%-0.0035 | -204.76%-0.0064 | -349.95%-0.0048 | 40.82%-0.0477 | 45.03%-0.0365 | -22.24%-0.0084 | -210.53%-0.0021 | 92.84%-0.0011 | -154.55%-0.0806 | -404.52%-0.0664 |
| Diluted earnings per share | 58.33%-0.0035 | -204.76%-0.0064 | -349.95%-0.0048 | 40.82%-0.0477 | 45.03%-0.0365 | -22.24%-0.0084 | -210.53%-0.0021 | 92.84%-0.0011 | -154.55%-0.0806 | -404.52%-0.0664 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.